Blood Transfusion Diagnostics Market – Product Development is the best strategy for market position; Forecast till 2023

 Blood Transfusion Diagnostics Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.

The Global Blood Transfusion Diagnostics Market is expected to rise to valuation of USD 2.45 billion by 2023, rising at a CAGR of 8.2% over its 2016 value of USD 1.5 billion, according to the latest research report from Market Research Future (MRFR). The global blood transfusion diagnostics market is mainly driven by the growing demand for blood transfusions and the growing demand for ensuring safe blood transfusions. The global blood transfusion diagnostics market is assessed in great detail in the report, which provides a thorough review of the market’s key drivers and restraints, leading segments, and major market players.

Also Read : https://www.medgadget.com/2019/08/blood-transfusion-diagnostics-market-2019-global-growth-status-share-demand-size-business-insights-and-region-wise-forecast-to-2023.html 

The global blood transfusion diagnostics market is mainly driven by the growing demand for blood transfusions. The blood transferred during blood transfusions has to be checked for diseases before being transferred to another patient, as bloodborne diseases can be contracted by the recipient. This has led to a growing demand for strong blood transfusion diagnostics infrastructure. In developed regions, the blood transfusion diagnostics infrastructure is widespread and strong due to the high number of blood transfusion procedures carried out in these regions. The receiver of the blood as well as the medical staff are susceptible to diseases contained in donated blood, making it likely that the blood transfusion diagnostics market will grow at a stable growth rate over the forecast period.

The increasing prevalence of infectious diseases and the growing awareness about the need for effective blood transfusion diagnostics are also likely to be major drivers for the global blood transfusion diagnostics market over the forecast period. Infectious diseases are a major concern for the global healthcare sector, making it likely that the global blood transfusion diagnostics market will receive stable government support over the coming years, leading to steady growth of the market.

Industry News:

In June 2019, Dubai Health Authority (DHA) announced the launch of its blood donation campaign, ‘Be the Hero … Save Lives’ for encouraging donators and creating awareness.

In June 2019, The American Chamber of Commerce in Việt Nam (AmCham Vietnam) collaborated with HCM City Institute of Hematology, and Blood Transfusion organized a blood donation campaign to celebrate the World’s Blood Donor Day on 14^th of the month.

In February 2019, a two year old in the Tamil Nadu state of India was alleged to have contracted HIV from a blood transfusion. Further enquiries cleared the hospital staff of any wrongdoing, as the source of the HIV was ascertained to be something other than the transfusion. Such incidents reveal the need for strong blood transfusion diagnostics infrastructure, especially in emerging countries.

In January 2019, a leader in transfusion and transplantation diagnostics, Immucor, Inc., has announced that it has received approval from Health Canada for its next-gen fully automated Echo® instrument, Echo LumenaTM.

Key Players for Global Blood Transfusion Diagnostics Market

The prominent players participating in the share assessment of the global blood transfusion diagnostics market are Thermo Fisher Scientific, Inc. (U.S.), Grifols (Spain), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), BioMérieux (France), Immucor (U.SOrtho Clinical Diagnostics, Inc. (U.S.), ),  Becton, Dickinson and Company (U.S.), Siemens Healthineers (Germany), Beckman Coulter, Inc. (U.S.), Novartis AG (Switzerland), Ortho Clinical Diagnostics (U.S), Diagast (France), Abbott Diagnostics (U.S), Beckman Coulter (U.S), BAG healthcare (Germany),  Fujirebio (Belgium), DiaSorin (Italy), Grifols (Spain), Hologic/Gen-Probe (U.S), Quidel (U.S), and Biokit (Spain).

Segments for Global Blood Transfusion Diagnostics Market

The global blood transfusion diagnostics market, on the basis of blood product, has been segmented into platelets, red blood cells, plasma, immunoglobulin preparations, albumin, and other products.

Based on technology, the blood transfusion diagnostics market has been segmented into ELISA, nucleic acid amplification, rapid test, western blot, fluorescence assay, and others. The ELISA segment has been sub-segmented into fluorescence immunoassays (FIA), chemiluminescence immunoassay (CLIA), and colorimetric immunoassay (CI). The nucleic acid amplification segment is sub-divided into Thermomechanical analysis (TMA) and real-time PCR.

By end-users, the global blood transfusion diagnostics market has been segmented into clinics, blood banks, hospitals, laboratories.

Regional Analysis for Global Blood Transfusion Diagnostics Market

The global blood transfusion diagnostics market, on the basis of region, has been segmented into four key regions, viz. Europe, Asia Pacific, Americas, and the Middle East and Africa (MEA). Americas is prognosticated to account for the maximum market share in the forthcoming years. The growth can be ascribed to the rising adoption of nucleic acid amplification test. In addition, the increasing count of road accidents is also poised to favor market growth in the region. Europe is in the second spot and is likely to grow significantly over the next couple of years. The rising awareness about blood donation and investments in blood donation campaigns are anticipated to boost revenue generation for the market players. Asia Pacific is also prognosticated to exhibit rapid developments. The exponential population growth of the region is likely to benefit the growth pattern of the blood transfusion diagnostics market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Cardiac Pacemaker Market Estimated to Witness a Staggering Growth by 2023

 Global Cardiac Pacemaker Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

MRFR is the Leading Brand in The Research Company Who Recently Published Global Cardiac Pacemaker Market Research Reports which includes Study of Growth Overview, Regional Analysis, Top Players, Major Drivers, Upcoming Trends and Foreseen to 2023

Prominent names in the Global Cardiac Pacemaker Market are Medtronic (U.S.), Abbott. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK (Germany), LEPU MEDICAL (U.K), SORIN Group (Europe), MEDICO S.p.A. (Europe), OSCOR Inc. (U.S.), and others.

Also Read : https://www.medgadget.com/2019/09/cardiac-pacemaker-market-insights-2019-competitive-players-size-value-demand-regional-outlook-type-technology-restrains-and-foreseen-by-mrfr-till-2023.html 

Market Overview:

The Global Cardiac Pacemaker Market is expecting a 7.9% CAGR during the forecast period (2017-2023) to claim substantial market valuation by the end of 2023, asserts Market Research Future (MRFR). This certain growth can be attributed to several factors from its functional features to its use in countering diverse health-related issues. Cardiac pacemaker’s use in maintaining regularity of the heart rhythm by sending electrical pulses to the heart has gained traction in treating atrial fibrillation (AFib) which is also the chief driver in taking the cardiac pacemaker market ahead. Furthermore, the rising geriatric population, with a predicted number of 2.1billion by 2050, is expanding the cardiac pacemaker market horizon.

However, cardiac pacemakers incur high cost which can be a hurdle for the cardiac pacemaker market during the forecast period. At the same time, its implantation procedure requires surgery and risks of malfunctioning can add further woe.

Industry Trend:

Researchers at the University of Ottawa Heart Institute completed the first successful implant in 2018 of a Micra Leadless Transcatheter Pacing System, which is the latest model of its category and the smallest leadless pacemaker in the world. The process allows the machine to be implanted directly within the heart, unlike other pacemakers.

Practitioners at Children’s Hospital Los Angeles and the University of Southern California have developed a micropacemaker system requiring implantation in the pericardial sac which could be a breakthrough in cardiac surgery options for children and adults.

Segment Analysis

The global cardiac pacemaker market can be segmented by type, technology, application, and end-users.

Based on type, the cardiac pacemaker market includes implantable, external cardiac pacemaker, and others.

Technology-wise, the cardiac pacemaker market comprises biventricular, single-chambered, dual-chambered, and others.

Application-based segmentation of the cardiac pacemaker market consists arrhythmias, congestive heart failure, and others. Arrhythmias segment can be sub-segmented into tachycardia, bradycardia, and others.

Based on the end-users, the market cardiac pacemaker includes hospitals, cardiac care centers, medical institutes, and others.

Regional Analysis

Geographical analysis of cardiac pacemaker market includes regions namely the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas has the lead in the global market, and they can attribute this to a superior infrastructure, and better healthcare policies. Furthermore, a considerable patient pool is also playing in favor of cardiac pacemaker market. Changing lifestyle and high healthcare expenditure are proving essential for the regional market growth.

Europe is following the lead and is experiencing considerable growth owing to regular investment in research and development. Governments taking a keen interest in the sector has a positive impact on the market.

The APAC is the fastest growing region with India and China continually improving their industrial landscape. In addition, many countries of this region are emerging as a medical tourism hub and helping the regional cardiac pacemaker market witness unprecedented growth. The MEA region’s growth will be slow due to lack of infrastructure and poor economic regions.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/cardiac-pacemaker-market-2025

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Global Robotics Prosthetics Market is Expected to Experience Immense Growth During 2020 – 2023

 The exclusive research report on the Global Robotics Prosthetics Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

The Global Robotics Prosthetics Market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 9.5% during the forecast period (2016-2027). Robotics prosthetics can be referred to as an artificial limb, which improves the lifestyle and function of a person with a missing body part.

The rising number of trauma cases and accidents and surging incidences if chronic diabetes has increased the number of amputation surgeries in the U.S.  Robotics prosthetics help to mimic the functionality and appearance of missing body parts. The type of prosthetics always depends on the stability, size, use, type, and age of the person. Thus, consumers prefer customized robotics prosthetics depending on their requirements. The soaring demand for customized prosthetics will thus drive the robotic prosthetics market in the foreseeable future.

Also Read : https://www.medgadget.com/2019/09/robotics-prosthetics-market-2019-top-companies-growth-strategies-demand-size-trends-revenue-analysis-industry-news-price-factors-and-forecast-to-2027.html 

The advent of mind-controlled humonics is considered one of the most vital robotic prosthetic trends that is likely to impact the market growth, especially in the U.S. It helps to fulfill the unmet needs of volitional control and lost sensation and development of aesthetics like gestures, which is not possible with orthopedic prosthetics. With sensory feedback technology, humonics offer mind-controlled and user-centric prosthetics, thereby providing users complete control. Such advancements are estimated to encourage the market growth in the long run.

On the contrary, robotic prosthetics are not well covered under insurance policies, which is likely to deter the market growth. Additionally, these prosthetics are expensive, thus making them inaccessible to the users. This is likely to restrict the market growth in the foreseeable future.

Key Players – Robotics Prosthetics Market

The Global Robotics Prosthetics Market is highly fragmented with the presence of many local players and international players. The main focus of these players is cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through collaborations and partnerships to expand their overall market share.

The top players operating in the robotics prosthetics market include Touch Bionics Inc. (U.S.), HDT Global Inc (U.S.), Shadow Robot Company (U.K), SynTouch, LLC (U.S.), Smith & Nephew (U.K), Stryker Corporation (U.S.), ReWalk Robotics (Israel), Aethon (U.S.), KUKA Roboter GmbH (Germany), Medrobotics Corporation (U.S.), Mazor Robotics Ltd. (Israel), Intuitive Surgical, Inc. (U.S.), Transenterix, Inc. (U.S.), Hansen Medical, Inc. (U.S.), and ZOLL Medical Corporation (U.S.).

Industry Update

August 2019: An all-new electronic skin system, Asynchronous Coded Electronic Skin is equipped with ultra-high responsiveness and is capable of pairing with any sensor skin layers in order to function efficiently as an electronic skin. This artificial nervous system can give prosthetic devices and robots a sense of touch, which is better than human skin.

June 2019: A mechatronics graduate from Simon Fraser University has designed a 3D printed humanoid robot finger that can mimic the strength and tenderness of a human hand. Robots equipped with these flexible fingers can be used to help people with mobility challenges as well as limb differences.

Regional Analysis – Robotics Prosthetics Market

Middle East & Africa, Asia Pacific, the Americas and Europe are the key markets for robotics prosthetic.

Largest portion of the robotics prosthetics market is controlled by the Americas. Robust demand for robotic prosthetics in the United States (U.S.) results in regional dominance. Government support in the form of investments for developing technologically advanced prosthetic limbs for veterans and soldiers benefits the market. The Centers for Disease Control and Prevention revealed in 2015 that the high number of osteoporosis cases as well as low bone mass at the femur neck in the U.S. are prevalent mostly in adults aged 50 years. Besides, the highest prevalence of osteoporosis has been recorded among Mexican-American adults accounting for 24.9%, with the condition affecting about 15.7% of the non-Hispanic white adults. These factors are promoting market growth in the region, MRFR reports.

Europe stands as the second-biggest market for robotics prosthetics. The market growth is in response to the growing government support with respect to research and development in the robotics prosthetics fields. France and Germany witness massive investment in the healthcare domain, which makes them the top contributing countries in the region.

Asia Pacific notes the fastest growth rate in the worldwide market. In the region, India and China could note fast-track growth on account of the expanding aging population and the mounting awareness about advanced technology. Surging amount of funds for research and development, as well as the availability of best treatment options, add to the market strength. Increasing demand for sophisticated healthcare facilities as well as gadgets also pushes market growth to a great extent. Another critical factor could be the lower cost of treatment compared to other regions.

Middle East and Africa accounts for the smallest market for robotics prosthetics due to scarce investment and substandard healthcare infrastructure.

Segmentation – Robotics Prosthetics Market

The Global Robotics Prosthetics Market has been segmented on the basis of technology, product, application, and end user.

By product, the market is segmented into prosthetic feet/ankles, prosthetic arms, prosthetic hands, prosthetic legs/knees, and others.

By technology, the market is segmented into Bluetooth, prosthetic foot materials, myoelectric technology, microprocessor knees, and others.

By application, the market comprises lower body extremity and upper body extremity.

The end users segment comprises clinics, hospitals, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/robotics-prosthetics-market-1316 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Osteoarthritis 2020 Global Market Key Players, Analysis and Forecast to 2023

 An expert on premium research reports, Market Research Future has added a report titled "Global Osteoarthritis Market 2023" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

Osteoarthritis is leads to the breakage of the joint cartilage and is one of the most common forms of arthritis. Osteoarthritis can cause immense pain, swelling, and a limited motion in affected joints. Usually, hands, knees, hips and the spine are highly probable to be affected by osteoarthritis. As per the report by Market Research Future (MRFR), the global osteoarthritis market is expected to ascend at a 6.8% CAGR through the forecast period.

Also Read : https://www.medgadget.com/2019/08/osteoarthritis-market-2019-size-trends-potential-growth-share-and-key-country-analysis-with-forecast-to-2023.html 

Some factors, as mentioned in the latest report by Market Research Future (MRFR) contributing to the ascension of the global osteoarthritis market include a rising prevalence of the geriatric population across the globe. Further, unhealthy lifestyle has led to a proliferation in the number of overweight individuals, magnifying the risk of osteoarthritis among consumers. An improvement in detection techniques has led to a rise in detection rates, driving the global osteoarthritis market. Other than that, improved accessibility to healthcare facilities has also contributed to the global osteoarthritis market growth by 2023.

Key Players for Global Osteoarthritis Market

The report has mentioned various players in the global osteoarthritis market including Abbott. (U.S.), Novartis AG (Europe), Pfizer Inc. (U.S.), Eli Lilly and Company (U.S.), ABIOGEN PHARMA S.p.A (Europe), Merck Sharp & Dohme Corp. (U.S.), TissueGene Inc. (U.S.), Ampio Pharmaceuticals Inc. (U.S.), Regeneron (U.S.).

Industry Update

June 2019: A treatment developed by biomedical engineers in the Cornell University uses a synthetic version of a joint lubricant to bind the surface of cartilage in joints. It acts as a cushion during heavy activities such as running. This treatment is currently in canine clinical trials and will be eventually used in humans.

March 2019: Researchers from the Kennedy Institute of Rheumatology at the University of Oxford, and Jenner Institute have collaboratively developed a vaccine that could be used to treat chronic pain caused by osteoarthritis. The virus-like particle vaccine is capable of triggering the immune system to produce antibodies which would help to block naturally-occurring NGF and alleviate osteoarthritis pain.

Segmental Analysis

The global osteoarthritis market is studied for various segments based on type, diagnosis, treatment, end-users, and region. Based on type, the global osteoarthritis market is segmented into hip osteoarthritis, wrist osteoarthritis, and spinal osteoarthritis. Based on end-user, the osteoarthritis market is segmented into research organization, medical institutes, and hospitals & clinics.

Based on diagnosis, the global osteoarthritis market is segmented into imaging, and joint fluid analysis. Among these segments, the imaging segment is further sub-segmented into X-rays, and magnetic resonance imaging (MRI).

Based on treatment, the osteoarthritis market is segmented into medication, surgery, and therapy. The medication segment is further sub-segmented into non-steroidal anti-inflammatory drugs and analgenics. The analgenics segment is further segmented into acetaminophen and duloxetine. The non-steroidal anti-inflammatory drugs segment is further sub-segmented into ibuprofen, aspirin, naproxen, and naproxen sodium.

Regional Analysis of Global Osteoarthritis Market

The global osteoarthritis market is segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. Among these segments, the Americas are expected to spearhead the global osteoarthritis market over the forecast period. This market domination can be owed to a well-developed healthcare sector and a massive patient population residing in the region. Additionally, changing lifestyle and an increasing healthcare expenditure have also contributed to the ascension of the regional osteoarthritis market.  In 2015, a report by the Centre for Disease Control and Prevention, 17.8% of US’s total GDP accounted for the country’s healthcare expenditure, which came to USD 3.2 trillion.

Europe, on the other hand is anticipated to follow the Americas and owe for the second largest osteoarthritis market during the forecast period. Such market growth can be attributed to the rising availability of funds for research and a huge patient population for osteoarthritis. Further, increasing healthcare expenditure in the region, along with a well-developed healthcare sector and government support for R&D projects are boosting growth in the regional osteoarthritis market over the review period. Western Europe is anticipated to hold the largest share in the regional osteoarthritis market with Germany, France, and the UK at the forefront. However, Eastern Europe is estimated to grow at a relatively faster rate owing to expansion opportunities for various market players.

Asia Pacific is anticipated to grow at the fastest rate during the forecast period, owing to the presence of a massive patient population and the presence of significant developing countries such as China and India. Further, humongous growth opportunities for various international and regional market players are expected to drive the market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/osteoarthritis-market-1609

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Pharmacogenomics Market | Worldwide Top key Players Profile Analysis | Forecast till 2023

 This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Pharmacogenomics Market over the forecast period.

Pharmacogenomics Market: Segmental Analysis

The global market for pharmacogenomics has been segmented on the basis of technology, application, and end user.

The types of technology in the market include microarray, sequencing, polymerase chain reaction, and others. The sequencing segment is further segmented on the basis of Sanger sequencing, pyrosequencing, next-generation sequencing, and others.

Also Read : https://www.medgadget.com/2019/11/pharmacogenomics-market-2019-by-size-share-latest-innovation-industry-trends-growth-factors-demands-opportunities-key-players-analysis-forecast-2023.html 

The segments based on application are oncology, cardiology, neurological disorders, and others. The oncology segment can be considered for breast cancer, lung cancer, and others.

On the basis of end users, the market is segmented into hospitals, research organizations, academic institute, and others.

Market Drivers and Top Barriers

According to Market Research Future (MRFR), the Global pharmacogenomics market is projected to expand at a CAGR of 5.8% over the forecast period (2017-2023).

The deciding factors in the pharmacogenomics market growth include the surging expenditure in research and development (R&D) along with the elevating rate of adverse reactions. World over, there has been a rising focus on precision medicine coupled with the growing need for drug safety as well as efficacy, which has led to the market expansion in recent years.

On that note, the strong focus on precision medicine is striving to expand the pharmacogenomics market, as the primary aim of precision medicine is integrating genetic as well as environmental information of certain diseases along with their responses to specific treatments. This factor helps in targeted drug therapies, in addition to the growing adoption of treatment procedures that reduce the side effects and achieve accurate results, which makes extensive use of pharmacogenomics. For instance, in 2015, the United States (U.S.) government had implemented a new precision medicine initiative to augment the development of individualized care, which includes genetic variability for a variety of chronic disorders.

Additionally, the rapid growth in the number of research studies associated with sequencing, particularly next-generation sequencing, will raise the demand for pharmacogenomic tests in the years to come. This factor will play an integral role in market growth to a large extent.

Market Opportunities

Pharmacogenomics is considered to be a vital aspect in terms of cancer treatment, having proved to be a favorable option helping with the survival of patients. Over and above that, pharmacogenomics also has managed to reduce the additional cost owing to unresponsive treatment. Therefore, growing use of pharmacogenomics for the treatment of cancer has resulted in numerous significant discoveries, which is bound to contribute to the growth of the worldwide market in the upcoming period.

Pharmacogenomics Market: Competitive Analysis

• Assurex Health Inc. (U.S.),
• Pathway Genomics (U.S.),
• Teva Pharmaceutical Industries Ltd. (Israel),
• Myriad Genetics, Inc. (U.S.),
• GeneDx. (U.S.),
• Future Science Group (U.S.),
• GeneTech (U.S.),
• 23andMe, Inc. (U.S.)

Pharmacogenomics Market: Latest Industry Updates

May 2019: Premier Health Group has partnered with Navigator Genomics (NGT), in a bid to offer access to their Pharmacogenomic Testing. This testing will be for medical cannabis along with 416 of the popular medicines. This will ensure that the patients are provided with the best medical drugs, avoiding the medication that are not effective.

October 31, 2018: The U.S. Food and Drug Administration has recently announced that they have approved the marketing of 23andMe’s reports on pharmacogenetics. The genetic-testing company claims are designed to assess whether the genetics will affect an individual’s ability to metabolize certain drugs which include antidepressants.

Nov 2017: Myriad Genetics, Inc., announced positive results from a double-blind, multi-center, randomized controlled trial assessing the impact of the GeneSight Psychotropic test (GeneSight) on psychiatric treatment response in 1,200 patients with major depressive disorder. GeneSight is one of the leading pharmacogenomics test to help guide medication selection for mental health disorders.

Pharmacogenomics Market: Regional Analysis 

The pharmacogenomics market is spread across the primary regions of the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas has been identified as the dominant region in the global pharmacogenomics market, on account of highly-developed healthcare industry coupled with the inclusion of developed countries such as the United States (U.S.) as well as Canada. Furthermore, the expansion of the patient pool suffering from cardiovascular diseases as well as the growing healthcare expenditure is nurturing the growth of the regional market. As per the Centers for Diseases Control and Prevention, in 2015, heart disease had been the main cause of death for men as well as women in the U.S. In addition, the analysis suggested that the spending on healthcare for heart diseases in the country touches the valuation of USD 200 billion every year.

Data analysts concur that Europe stands second in the global pharmacogenomics market, with the Asia Pacific following suit. The surge in the funds for research and development on top of the increasing government support and the expanding patient population will prove to be instrumental in the market growth. Plus, the region also benefits from the primary contribution of the developed nations such as France and Germany with excellent growth prospects in the medical field.

Racing ahead at the fastest growth rate is the region of Asia Pacific, with the primary reasons being the burgeoning patient pool and the progressively growing economies such as India and China in the region. The Indian Brand Equity Foundation had reported in 2016 that the biotech industry in India is expected to arrive at the valuation of USD 100 billion by the year 2025, crossing the value of USD 7 billion it had reached in 2015. The industry is also expected to expand at a growth rate of 30.46% in the mentioned evaluation period, as per reports.

Meanwhile, the growth of the Middle East & Africa market has been inferior to other regions in the global pharmacogenomics market. This stunted growth can be the result of the poor economy, low expenditure on healthcare, and the rigid government policies, particularly in Africa. Concurrently, the substantial portion of the regional market is controlled by the Middle East, with the backing from the well-established healthcare industry combined with the growing healthcare expenditure. Apart from this, developed countries such as Dubai, Saudi Arabia, and Qatar have a big hand in the growth of the Middle East & Africa market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Companion Animal Healthcare Market Poised to Witness a Significant Growth by 2023

 Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Companion Animal Healthcare Market Research Report - Forecast to 2023” Gives industry size, top players and worldwide demand

The Global Companion Animal Healthcare Market is predicted to touch USD 20 billion at a 9.6% CAGR over the forecast period (2017-2023), as per the latest Market Research Future (MRFR) report.

Segmentation – Companion Animal Healthcare Market

The Market Research Future report provides a wide segmental analysis of the companion animal healthcare market based on end users, diagnostic tests, and product.

Also Read : https://www.medgadget.com/2019/11/companion-animal-healthcare-market-2019-share-size-trends-growth-regional-analysis-with-global-industry-forecast-to-2023.html 

Based on product, the companion animal healthcare market is segmented into vaccines, pharmaceuticals, and feed additives. The feed additives segment is again segmented into medicinal feed additives and nutritional feed additives. The nutritional feed additives segment is further segmented into vitamins, minerals, and proteins, and medicinal feed additives are further segmented into probiotics and prebiotics, immune-modulators, enzymes, hormones, and others. The pharmaceutical products segment is further segmented into anti-inflammatories, antibiotics, and anti-infectives. Of these, the pharmaceutical products segment will have the largest share in the market over the forecast period. This is owing to the rising prevalence of food-borne diseases, brucellosis as well as other zoonotic diseases which are hazardous to animals.

Based on diagnostic tests, the companion animal healthcare market is segmented into molecular diagnostics, immunodiagnostic tests, diagnostic imaging, and others. Of these, the diagnostics imaging segment will dominate the market over the forecast period. This is owing to rising zoonotic infections that is boosting the need for establishing point-of-care testing and diagnostics laboratories.

Based on end users, the companion animal healthcare market is segmented into home care, veterinary clinics, and veterinary hospitals. Of these, the veterinary clinics and veterinary hospitals will lead the market over the forecast period. This is owing to the accessibility of a huge variety of diagnostic options.

Market Overview nd Drivers 

Companion animals are used for amusement, company, extrovert display, psychological support, and other functions which humans require for sharing with animals. A yearly veterinary checkup is one of the finest means of keeping the pet healthy.

Various factors are propelling the companion animal healthcare market growth. These factors, as stated by the MRFR report, include growing pet adoption across the world, increasing government initiatives for animal health, growing advancements in technology in animal healthcare, and increasing nuclear families that have accelerated the trend of pet ownership. Additional factors pushing market growth include growing investments made by key players for developing advanced pet care solutions, increasing awareness about animal cruelty, advances in animal vaccines and health medicines, and increased types of medical treatment.

Key Players – Companion Animal Healthcare Market

Leading players profiled in the companion animal healthcare market report include

• Boehringer Ingelheim (Germany),
• Perrigo Company plc (Ireland),
• Vetoquinol S.A. (France),
• Bayer Animal Health (Germany),
• Elanco Animal Health (US),
• Merial (France),
• Virbac Animal Healthcare (France),
• Ceva Animal Healthcare (UK),
• Merck and Co., Inc. (US), 
• Zoetis Animal Healthcare (US),

among others. Key players have acquired several strategies to gain a competitive edge in the market. This include product launch, expansion, partnership, collaboration, and acquisition.

Competitive Analysis – Companion Animal Healthcare Market

Characterized by the presence of several well-established and small players, the global Market of Companion Animal Healthcare appears to be highly competitive and fragmented. International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing.  The Market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

However, well established players integrate acquisition, collaboration, partnership, expansion, and product launch to gain competitive advantage in this market.

For instance; innovative Seresto collar by Bayer to protect dogs and cats against diseases transmitted by parasites. These key players offer a broad range of products with a range of treatment options, especially for bacterial infections.

Zoetis Animal Healthcare is one of the global animal healthcare company provides wide range of products for animal care. Moreover, company provides specific products for dogs, cats and horses. For instance, Apoquel, Cerenia, Convenia, Cytopoint, Palladia, Rimadyl are the products for dogs.

Regional Analysis – Companion Animal Healthcare Market

Based on the region, the companion animal healthcare market report covers the latest trends and growth opportunities across the Asia Pacific, Europe, the Americas, and the Middle East and Africa. Of these, the Americas will spearhead the market over the forecast period. This is owing to the availability of a huge variety of animal health products.

The companion animal healthcare market in Europe is predicted to have the second-largest share in the market over the forecast period. This is due to an increase in pet ownership on account of tax benefits offered by the government.

The companion animal healthcare market in the APAC region is predicted to have a positive and steady growth over the forecast period. This is owing to the rising awareness about animal cruelty that has influenced people awareness as well as ideologies towards animals.

The companion animal healthcare market in the Middle East and Africa is predicted to have a steady growth over the forecast period. This is owing to high growth opportunities on account of financial improvement and an associated increase in disposable income.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/companion-animal-Healthcare-market-1168 
About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Smart Contact Lenses Market is Growing Massively till 2023

 Market Research Future adds the “Smart Contact Lenses Market Research Report - Forecast to 2023” report to their unique collection.

The Smart Contact Lenses Market to touch the valuation of USD 7.2 billion in 2023, says Market Research Future (MRFR). MRFR also states that the market is slated to achieve a CAGR of 10.4% during the forecast period (2018-2023).

Global Smart Contact Lenses Information, By Application (Continuous Glucose Monitoring, Intraocular Pressure Monitoring), By End User Type (Hospitals, Clinics And Home Care Settings) – Forecast Till 2023

The smart contact lenses market has grown significantly in response to the surging geriatric population and the mounting demand for eye care solutions. The rising adoption of wearable medical devices coupled with the high prevalence of glaucoma and diabetes benefits the market as well. Technological developments in wearable electronics, as well as wireless communication, have turned out to be a vital tool leading to the realization of several medical applications using health monitoring technologies. Smart contact lenses are used to monitor the physiological information of eye as well as tear fluid, providing non-invasive, real-time medical diagnostics.

Also Read : https://www.medgadget.com/2019/09/smart-contact-lenses-market-size-share-analysis-current-dynamics-business-opportunities-trends-growth-of-leader-companies-and-foreseen-by-2023.html 

It is reported that glaucoma affects close to 67 million people around the world and is the main cause of irreversible vision loss and blindness. Smart contact lenses help obtain spontaneous deviations within the eyes and allow the physicians to treat glaucoma backed with essential information. If these reasons are factored in, then the market growth is inevitable during the evaluation period.

Smart contact lenses are considered to be a promising noninvasive solution to monitor glucose. Smart contact lenses with microsensor used for analyzing glucose levels is touted to be life-changing technology within the healthcare sector. Considering various benefits of this technology, the information technology vendors are making moves to capture related technologies in a bid to expand their market presence.

Market Players:

• Sensimed SA (Switzerland),
• Alcon (U.S),
• Sony (Japan),
• Google (U.S),
• Samsung (South Korea),

are the key contributors of the smart contact lenses market.

Industry Update:

July 2019 IMT Atlantique, a French engineering institute, has developed the world’s first micro battery which could work against the challenge of small-scale energy storage during the development of smart contact lenses. This technology has grabbed the attention of the US military and someday could deliver improved visual capabilities along with medical and automotive assistance for them.

March 2018 Theraoptix recently took home the MIT Sloan Healthcare Innovation Prize at their annual competition’s and also received a $25,000 grand prize which was sponsored by Optum, a health services firm. The contact lens is made from FDA-approved materials and delivers eye medication in a sustained and controlled release. The lens is sandwiched between contact lens material which is a drug-filled polymer film and shaped into a tiny circular strip that does not interfere with the wearer’s vision. The sandwiching structure allows the drugs to seep from the film into the eye gradually.

Segments:

The market for smart contact lenses has been segmented on the basis of application and end-users.

The global smart contact lenses market, depending on the application, cover intraocular pressure monitoring, continuous glucose monitoring, and others. Other applications include sodium detection, alcohol detection, and cholesterol detection.

The end users of smart contact lenses are hospitals, clinics, and home care settings.

Regional Analysis:

The main markets for smart contact lenses are Europe, the Americas, Middle East, and Africa and Asia Pacific.

The Americas is considered to be the leading market for smart contact lenses. Huge pool of diabetic population and the surge in demand for eye care solutions with innovative technology have a big hand in the said growth. The rising adoption of sophisticated wearable medical devices, as well as trends in cosmetics, favors the market growth to a great extent. Also, the mounting awareness about fitness along with the availability of wearable medical devices in the region boosts market growth. With the boost in demand for self-monitoring devices, expanding aging population with eye disorders related to diabetes and the user-friendliness of smart contact lenses will do wonders for the regional market growth. The region is also known for developing highly innovative products for eye care as well as diabetes management, which has led to significant market growth over the years.

Europe, as the second leading smart contact lenses market, benefits from the rise in expenditure on research in smart medical devices. The growing use of smart contact lenses in a number of countries bodes well with the market growth in the region. In 2015, the data released by the World Health Organization (WHO) said that more than 60 million people in the region suffered from diabetes. These statistics indicate the rising need for smart contact lenses in the region, resulting in market expansion.

Prevalence of chronic diseases like diabetes and the presence of profitable countries like India and China could lead the Asia Pacific market to greater heights in the next few years. The growing disposable income and the improving economy of the countries in the region are expected to benefit the smart medical devices market.

Middle East and Africa could demonstrate sluggish market growth on account of low technology penetration. There is a rising demand for primary care services in Africa; however the lack of advanced medical care could hold back the region from growing in the near future.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/smart-contact-lenses-market-1186

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com